MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways

Hirotaka Hoshi1, Tetsuji Sawada, Motoyuki Uchida

  • 1Biomedical Research Laboratories, Kureha Corporation, Shinjuku-ku, Tokyo 169-8503, Japan.

Insights

Mucin 5AC (MUC5AC) knockdown suppresses pancreatic cancer growth by enabling neutrophil-mediated tumor cell apoptosis. MUC5AC inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Previous studies showed MUC5AC siRNA suppressed in vivo tumor growth and metastasis without affecting in vitro cell characteristics.
  • The specific host immune cells and mechanisms responsible for MUC5AC's in vivo effects remained unclear.

Purpose of the Study:

  • To identify the host immune cells mediating the antitumor effects of MUC5AC knockdown.
  • To elucidate the mechanism by which MUC5AC influences tumor cell susceptibility to immune attack, specifically TRAIL-induced apoptosis.

Main Methods:

  • Utilized immunocyte-depleted animal models (nude mice) to assess tumor growth after MUC5AC knockdown.
  • Administered anti-Gr-1 mAb to deplete neutrophils and observed effects on SW1990/si-MUC5AC tumor growth.
  • Investigated the impact of MUC5AC on TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by measuring active caspase 3 expression.

Main Results:

  • Depletion of neutrophils using anti-Gr-1 mAb restored tumor growth of SW1990/si-MUC5AC cells, indicating neutrophils mediate the antitumor effect.
  • MUC5AC knockdown cells (SW1990/si-MUC5AC) exhibited significantly increased active caspase 3 expression upon TRAIL treatment compared to control cells.
  • MUC5AC appears to protect tumor cells from TRAIL-induced apoptosis, suggesting a mechanism for immune evasion.

Conclusions:

  • Neutrophils are key host immune cells suppressing MUC5AC-expressing pancreatic tumor growth.
  • MUC5AC inhibits neutrophil-mediated antitumor activity by preventing TRAIL-induced apoptosis in pancreatic cancer cells.
  • MUC5AC may serve as a diagnostic and prognostic biomarker in human pancreatic cancer.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...